MSLP : Summary for MUSCLE PHARM CORP COM USD0.001 - Yahoo Finance

U.S. Markets closed

MusclePharm Corporation (MSLP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.75-0.02 (-1.19%)
At close: 3:32PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close1.77
Bid0.00 x
Ask0.00 x
Day's Range1.71 - 1.76
52 Week Range1.29 - 3.20
Avg. Volume13,295
Market Cap24.21M
PE Ratio (TTM)-1.11
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Arnold Schwarzenegger Lost A Bundle On Musclepharm Corp (MSLP), Says Hasta La Vista
    Insider Monkey8 days ago

    Arnold Schwarzenegger Lost A Bundle On Musclepharm Corp (MSLP), Says Hasta La Vista

    Arnold Schwarzenegger is known as a shrewd investor. Unfortunately he lost more than 80% on at least some of his investments in Musclepharm Corp (MSLP) over the last 3.5 years. During the summer of 2013 Arnold Schwarzenegger -one of the greatest muscle growth champions of all time- disclosed a 7.7 stake in MSLP whose shares […]

  • PR Newswire3 months ago

    MusclePharm Announces Hiring Of New Chief Financial Officer

    DENVER, Dec. 2, 2016 /PRNewswire/ -- MusclePharm Corporation (MSLP) ("MusclePharm" or the "Company"), a scientifically-driven, performance lifestyle sports nutrition company, today announced the appointment of Peter C. Lynch CPA as the Company's new Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer. Mr. Lynch has a diversified financial background spanning over 25 years, with financial leadership positions at several large corporations that include Kärcher North America, Inc., Honeywell International Inc. and Gates Corp.  Ryan Drexler, MusclePharm's President and Chief Executive Officer, and Chairman of the Board of Directors, said: "We are excited to have Peter join the organization and believe that his proven financial skills will be instrumental in assisting the Company in its continuing efforts to return to profitability and value creation.

  • PR Newswire3 months ago

    Wynnefield Commends Leadership Of MusclePharm CEO

    NEW YORK, Nov. 22, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), stockholders of MusclePharm Corp. (OTCQB: MSLP) ("MusclePharm" or the "Company") ...